For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    

  • All
  • Explainers
  • Achievements
  • Events
  • News
News

IAA clinical trial now open for recruitment

January 2023

ATIC is now seeking participants aged between 6 and 21 years with newly diagnosed type 1 diabetes for a ground-breaking Australian clinical trial.

Read more
News

Community Engagement Panel – calling for expressions of interest

November 2022

ATIC is seeking expressions of interest from members of the type 1 diabetes community who are interested in joining our Community Engagement Panel.

Read more
Events

October 28, 2022

Benchmarking cells for beta cell replacement therapies

3rd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Events

September 29, 2022

Harnessing T cell exhaustion to treat autoimmune disease

2nd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series

Read more
Events

August 10, 2022

August ATIC launch at Australian Diabetes Congress

We’re very excited to be officially launching ATIC at the upcoming ADC 2022 in Brisbane.

Read more
Events

August 26, 2022

New ATIC Seminar Series: commencing 26th August 2022

Introducing ATIC’s new seminar series ‘Beyond Insulin: Innovative research in T1D prevention and cure’. Join us for a new session each month!

Read more
News

ATIC Steering Committee meet for the first time

April 2022

Leading diabetes clinicians and researchers from across Australia gathered recently for the first meeting of the Australasian Type 1 Diabetes Immunotherapies Collaborative (ATIC) Steering Committee.

Read more
Explainers

Immunotherapy: harnessing our immune system against disease

March 2022

The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.

Read more
News

IMPACT trial commences in Australia

February 2022

In collaboration with Innodia, the ATIC network is leading IMPACT, a trial of a new medication called IMCY-0098 to determine whether it can preserve pancreas function in people with newly diagnosed type 1 diabetes.

Read more
Achievements

BANDIT trial filled

January 2022

Thanks to the generosity of the type 1 diabetes community, we have completed recruitment for the BANDIT trial.

Read more
News

Collaborative focused on immunotherapy in type 1 diabetes – ANZ first

January 2022

JDRF Australia has funded a first-of-its kind four-year collaboration, aimed at increasing the number of clinical trials available for Australians with type 1 diabetes – boosting the potential for new treatments.

Read more